These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 12854282)
1. [COX-2 inhibitors: a new treatment in rheumatic diseases]. Puddu G; Cravero E Clin Ter; 2003; 154(1):39-43. PubMed ID: 12854282 [TBL] [Abstract][Full Text] [Related]
2. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544 [TBL] [Abstract][Full Text] [Related]
3. Celecoxib: a COX-2 inhibitor. Andrews SA; Wallace CK; Davis RL Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389 [No Abstract] [Full Text] [Related]
5. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS J Rheumatol Suppl; 1999 Apr; 56():31-6. PubMed ID: 10225538 [TBL] [Abstract][Full Text] [Related]
6. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results. Tindall E J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176 [TBL] [Abstract][Full Text] [Related]
7. COX-2 inhibitors: new drugs for the management of pain and inflammation. Hutchins V; Hutchins B Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847 [No Abstract] [Full Text] [Related]
8. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results]. Oliw E; Wollheim FA Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877 [No Abstract] [Full Text] [Related]
9. COX-2 inhibitors. Brooks PM; Day RO Med J Aust; 2000 Oct; 173(8):433-6. PubMed ID: 11090038 [TBL] [Abstract][Full Text] [Related]
10. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice. Wolfe F; Michaud K; Burke TA; Zhao SZ J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808 [TBL] [Abstract][Full Text] [Related]
11. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines. Price-Forbes AN; Callaghan R; Allen ME; Rowe IF Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035 [TBL] [Abstract][Full Text] [Related]
12. [COX-2 inhibitor non-steroidal anti-inflammatory drugs, myth or reality?]. Peretz A Rev Med Brux; 2001 Sep; 22(4):A377-80. PubMed ID: 11680204 [TBL] [Abstract][Full Text] [Related]
13. Antiinflammatory and analgesic efficacy of COX-2 specific inhibition: from investigational trials to clinical experience. Bensen WG J Rheumatol Suppl; 2000 Oct; 60():17-24. PubMed ID: 11032098 [TBL] [Abstract][Full Text] [Related]
14. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective. Hochberg MC Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820 [TBL] [Abstract][Full Text] [Related]
15. An update on specific COX-2 inhibitors: the COXIBs. Gupta S; Crofford LJ Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091 [No Abstract] [Full Text] [Related]
16. [Celebrex: confirmed effectiveness and safety (new data)]. Nasonov EL Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753 [No Abstract] [Full Text] [Related]
17. Pain management in osteoarthritis: the role of COX-2 inhibitors. Lane NE J Rheumatol Suppl; 1997 Jul; 49():20-4. PubMed ID: 9249647 [TBL] [Abstract][Full Text] [Related]
19. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain]. Nasonova VA Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752 [No Abstract] [Full Text] [Related]